货号:A404664
同义名:
波生坦 一水合物
/ Ro 47-0203
Bosentan hydrate竞争性双重拮抗内皮素-1(ET)对ETA和ETB受体,在人体平滑肌细胞中Ki值分别为4.7 nM和95 nM。
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
产品名称 | ET-A ↓ ↑ | ET-B ↓ ↑ | 其他靶点 | 纯度 | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BQ-123 |
+++
Endothelin A receptor, IC50: 7.3 nM |
98% | |||||||||||||||||
Macitentan |
++++
ET-A, IC50: 0.5 nM |
+
ET-B, IC50: 391 nM |
98% | ||||||||||||||||
Zibotentan |
++
ET-A, IC50: 21 nM |
99%+ | |||||||||||||||||
Bosentan hydrate |
+++
ET-A, Ki: 4.7 nM |
++
ET-B, Ki: 95 nM |
98% | ||||||||||||||||
Ambrisentan | ✔ | 98% | |||||||||||||||||
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 |
靶点 |
|
描述 | G protein-coupled receptor (GPCR) agonists through their receptors can transactivate protein tyrosine kinase receptors such as epidermal growth factor receptor and serine/threonine kinase receptors most notably transforming growth factor (TGF)‐β receptor (TβRI). Several GPCR agonists such as Ang II, thrombin, ET-1 can mediate the transactivation of a multitude of protein tyrosine kinase receptors[3]. Endothelin (ET) is an endothelium-derived 21-residue vasoconstrictor peptide. The ETs have three distinct isoforms, namely ET-1, ET-2, and ET-3. ET-1 is the most abundant isoform and the best characterized in vivo, and it is the only one that is constitutively released by the vascular endothelium[4]. Bosentan hydrate (BST) is a competitive dual endothelin receptor antagonist that is nonselective for both endothelin A and endothelin B receptors with a Ki of 4.1 - 4.7 nM[5]. It decreases both pulmonary vascular resistance and systemic vascular resistance and hence increases cardiac output without increasing the heart rate[6]. In a vivo study, the rats were intragastrically administered with 100 mg/kg bosentan half an hour after Paraquat exposure, and then once a day. After bosentan administration, the ET-1 and TGF-β1 content of the serum and lungs gradually decreased and were markedly lower than in the Paraquat group on the 21st day which indicated that early treatment with bosentan after Paraquat poisoning may be helpful in ameliorating lung injury and decreasing lung fibrosis[4]. In a study, bosentan was given orally (1000 mg b.i.d.) for 14 days to patients who were also being treated for chronic heart failure (CHF) with digitalis, angiotensin-converting enzyme inhibitors (ACEIs) and diuretics and the results demonstrated that addition of bosentan to ongoing therapy for patients with CHF reduced systemic and pulmonary vascular resistance and increased cardiac index, without affecting heart rate. Bosentan treatment of patients with CHF already receiving ACEIs and diuretics significantly decreased plasma aldosterone levels[5]. |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
1.76mL 0.35mL 0.18mL |
8.78mL 1.76mL 0.88mL |
17.56mL 3.51mL 1.76mL |
CAS号 | 157212-55-0 |
分子式 | C27H31N5O7S |
分子量 | 569.629 |
别名 | 波生坦 一水合物 ;Ro 47-0203 |
运输 | 蓝冰 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form Sealed in dry,Room Temperature |
溶解方案 |
DMSO: 105 mg/mL(184.33 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 无水乙醇: 50 mg/mL(87.78 mM),配合低频超声助溶,注意:无水乙醇开封后,易挥发,也会吸收空气中的水分,导致溶解能力下降,请避免使用开封较久的乙醇 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
动物实验配方 |
2% DMSO+30% PEG 300+2% Tween 80+water 5 mg/mL |